{"id":476402,"date":"2020-03-26T13:24:01","date_gmt":"2020-03-26T13:24:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=476402"},"modified":"2020-03-26T13:24:01","modified_gmt":"2020-03-26T13:24:01","slug":"prostate-cancer-analysis-market-size-epidemiology-leading-companies-and-competitive-analysis-by-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/prostate-cancer-analysis-market-size-epidemiology-leading-companies-and-competitive-analysis-by-delveinsight_476402.html","title":{"rendered":"Prostate Cancer Analysis, Market Size, Epidemiology, Leading Companies and Competitive Analysis By DelveInsight"},"content":{"rendered":"
\"Prostate<\/a><\/div>\n

DelveInsight has launched a new report on Prostate Cancer Market Insights, Epidemiology and Market Forecast-2030<\/strong><\/p>\n

DelveInsight’s “Prostate cancer – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Prostate cancer, historical and forecasted epidemiology as well as the Prostate cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n

The Prostate cancer market report provides current treatment practices, emerging drugs, Prostate cancer market share of the individual therapies, current and forecasted Prostate cancer market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Prostate cancer treatment practice\/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.<\/p>\n

Prostate cancer<\/strong> begins when cells in the prostate gland—only found in males—start to grow uncontrollably. Prostate cancer affects the gland that nourishes and propels semenand plays a role in urine control in men.<\/p>\n

\"\"<\/p>\n

 <\/p>\n

Request for :- Prostate Cancer free sample page<\/a><\/p>\n

Epidemiology<\/strong><\/p>\n

The Prostate cancer epidemiology division provide insights about historical and current Prostate cancer patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.<\/p>\n

Report Key facts:- <\/strong><\/p>\n

1. According to theNational Cancer Institute, <\/strong><\/em>approximately 10–20% of prostate cancer cases are castration-resistant, and up to 16% of these patients show no evidence thatcancer has spread at the time of the castration-resistant diagnosis.<\/p>\n

2. According to the Prostate Cancer UK<\/strong>, over 47,500 men are diagnosed with prostate cancer every year—i.e. 129 men every day.  One in eight men will be diagnosed with prostate cancer in their lifetime.<\/p>\n

3. According to the Global Cancer Observatory, in 2018, there were 70,654; 212,783; 62,641; 64955; 43,837; 31,728; 56,401 new cases of prostate cancer reported in Japan, the United States, Germany, France, Italy, Spain, and the UK, respectively.<\/p>\n

Table of Contents<\/a><\/p>\n

1. Key Insights<\/span><\/p>\n

2. Executive Summary of Prostate cancer<\/span><\/p>\n

3. Competitive Intelligence Analysis for Prostate cancer<\/span><\/p>\n

4. Prostate cancer: Market Overview at a Glance<\/span><\/p>\n

4.1. Prostate cancer Total Market Share (%) Distribution in 2017<\/span><\/p>\n

4.2. Prostate cancer Total Market Share (%) Distribution in 2030<\/span><\/p>\n

5. Prostate cancer: Disease Background and Overview<\/span><\/p>\n

6. Patient Journey<\/p>\n

7. Prostate cancer Epidemiology and Patient Population<\/span><\/p>\n

8. Treatment Algorithm, Current Treatment, and Medical Practices<\/p>\n

9. Unmet Needs<\/p>\n

10. Key Endpoints of Prostate cancer Treatment<\/span><\/p>\n

11. Marketed Products<\/span><\/p>\n

12. Emerging Therapies<\/p>\n

13. Prostate cancer: Seven Major Market Analysis<\/p>\n

14. Attribute analysis<\/span><\/p>\n

15. 7MM: Market Outlook<\/span><\/p>\n

16. Access and Reimbursement Overview of Prostate cancer<\/p>\n

17. KOL Views<\/span><\/p>\n

18. Market Drivers<\/span><\/p>\n

19. Market Barriers<\/span><\/p>\n

20. Appendix<\/span><\/p>\n

20.1. Bibliography<\/span><\/p>\n

20.2. Report Methodology<\/span><\/p>\n

21. DelveInsight Capabilities<\/span><\/p>\n

22. Disclaimer<\/span><\/p>\n

23. About <\/strong>DelveInsight<\/a><\/p>\n

Why should you buy this report?<\/strong><\/p>\n